<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35275222</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>17</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>23</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1432-1041</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>78</Volume>
            <Issue>6</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>European journal of clinical pharmacology</Title>
          <ISOAbbreviation>Eur J Clin Pharmacol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Authors' reply to the letter to editor "Does Ramadan Fasting Affect the Therapeutic and Clinical Outcomes of Warfarin?".</ArticleTitle>
        <Pagination>
          <StartPage>1055</StartPage>
          <EndPage>1056</EndPage>
          <MedlinePgn>1055-1056</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s00228-022-03310-5</ELocationID>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Abbas</LastName>
            <ForeName>Kirellos Said</ForeName>
            <Initials>KS</Initials>
            <Identifier Source="ORCID">0000-0003-0339-9339</Identifier>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine, Alexandria University, Alexandria, Egypt.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rabea</LastName>
            <ForeName>Eslam Mohammed</ForeName>
            <Initials>EM</Initials>
            <Identifier Source="ORCID">0000-0001-8464-3959</Identifier>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine, Alexandria University, Alexandria, Egypt.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Abdelazeem</LastName>
            <ForeName>Basel</ForeName>
            <Initials>B</Initials>
            <Identifier Source="ORCID">0000-0002-2919-6196</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Internal Medicine, McLaren Health Care, Flint Michigan State University, 401 S Ballenger Hwy, Flint, MI, 48532, USA. baselelramly@gmail.com.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Michigan State University, East Lansing, MI, USA. baselelramly@gmail.com.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016422">Letter</PublicationType>
          <PublicationType UI="D016420">Comment</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>03</Month>
          <Day>11</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Germany</Country>
        <MedlineTA>Eur J Clin Pharmacol</MedlineTA>
        <NlmUniqueID>1256165</NlmUniqueID>
        <ISSNLinking>0031-6970</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000925">Anticoagulants</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>5Q7ZVV76EI</RegistryNumber>
          <NameOfSubstance UI="D014859">Warfarin</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <CommentsCorrectionsList>
        <CommentsCorrections RefType="CommentOn">
          <RefSource>Eur J Clin Pharmacol. 2022 Jun;78(6):1053-1054</RefSource>
          <PMID Version="1">35275223</PMID>
        </CommentsCorrections>
      </CommentsCorrectionsList>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000925" MajorTopicYN="N">Anticoagulants</DescriptorName>
          <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005215" MajorTopicYN="Y">Fasting</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D019934" MajorTopicYN="N">International Normalized Ratio</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014859" MajorTopicYN="Y">Warfarin</DescriptorName>
          <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>2</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>6</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>12</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>18</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>11</Day>
          <Hour>12</Hour>
          <Minute>12</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35275222</ArticleId>
        <ArticleId IdType="doi">10.1007/s00228-022-03310-5</ArticleId>
        <ArticleId IdType="pii">10.1007/s00228-022-03310-5</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Rabea EM, Abbas KS, Awad DM, Elgoweini NH, El-Sakka AA, Mahmoud NH, Abdelazeem B (2022) Does Ramadan fasting affect the therapeutic and clinical outcomes of warfarin? A systematic review and meta-analysis. Eur J Clin Pharmacol. https://doi.org/10.1007/s00228-022-03281-7</Citation>
        </Reference>
        <Reference>
          <Citation>Alghamdi M, Kokandi A, Alfadhil R, Alotaibi L (2018) Effect of Ramadan fasting on the international normalized ratio in patients with mechanical prosthetic heart valves. The Ulutas Med J 4(3).Â  https://doi.org/10.5455/umj.20180117091224</Citation>
        </Reference>
        <Reference>
          <Citation>Higgins JPT (2011) GSe Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]. The Cochrane Collaboration. Available from https://www.handbook.cochrane.org</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
